BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3173916)

  • 1. Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5.
    Riva P; Paganelli G; Callegaro L; Bartoli MG; Turci D; Benini S; Deleide G; Scassellati GA; Viale G; Siccardi AG
    Nucl Med Commun; 1988 Aug; 9(8):577-89. PubMed ID: 3173916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab')2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicenter study.
    Siccardi AG; Buraggi GL; Callegaro L; Colella AC; De Filippi PG; Galli G; Mariani G; Masi R; Palumbo R; Riva P
    Cancer Res; 1989 Jun; 49(11):3095-103. PubMed ID: 2655889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
    Chetanneau A; Baum RP; Lehur PA; Liehn JC; Perkins AC; Bares R; Bourguet P; Herry JY; Saccavini JC; Chatal JF
    Eur J Nucl Med; 1990; 17(5):223-9. PubMed ID: 2083556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma.
    Vuillez JP; Moro D; Brambilla E; Brichon PY; Ferretti G; Saccavini JC; Brambilla C
    Eur J Cancer; 1994; 30A(8):1089-92. PubMed ID: 7654435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody.
    Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R
    Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early immunoscintigraphic localisation of a mediastinal tumour with indium 111-DTPA CEA-specific F(ab')2 monoclonal antibody fragments (BW 431/31) using second tracer isocontour technique.
    Frohn J; Baum RP; Happ J; Falk S; Riemann HE; Hör G
    Eur J Nucl Med; 1990; 17(1-2):91-3. PubMed ID: 2083548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoscintigraphy of lung cancer using 111In-labelled antiCEA F023C5-F(ab')2 fragments.
    Torres M; Jiménez-Heffernan A; Valverde A; González FM; Latre JM; Llamas JM; Baamonde C; López-Rubio F; Mateo A
    Nucl Med Commun; 1991 Nov; 12(11):937-50. PubMed ID: 1661391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.
    Faivre-Chauvet A; Mease RC; Chetanneau A; Bardiès M; Sai-Maurel C; Meinken GE; Srivastava SC; Chatal JF; Gestin JF
    Nucl Med Commun; 1996 Sep; 17(9):781-9. PubMed ID: 8895905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
    Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
    Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
    Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
    J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment.
    Reiners C; Eilles C; Spiegel W; Becker W; Börner W
    Nuklearmedizin; 1986 Dec; 25(6):227-31. PubMed ID: 3808964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging lung cancer by scintigraphy with Indium 111-labeled F(ab')2 fragments of the anticarcinoembryonic antigen monoclonal antibody FO23C5.
    Buccheri G; Biggi A; Ferrigno D; D'Angeli B; Vassallo G; Leone A; Taviani M; Comino A
    Cancer; 1992 Aug; 70(4):749-59. PubMed ID: 1643607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of iodine and indium labelled anti CEA intact antibody, F(ab)2 and Fab fragments by imaging tumour xenografts.
    Andrew SM; Perkins AC; Pimm MV; Baldwin RW
    Eur J Nucl Med; 1988; 13(11):598-604. PubMed ID: 3350036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-guided diagnosis: an Italian experience on CEA-expressing tumours.
    Riva P; Moscatelli G; Paganelli G; Benini S; Siccardi A
    Int J Cancer Suppl; 1988; 2():114-20. PubMed ID: 3162439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoimaging of non-small cell lung cancer with 111In- and 99mTc-labeled monoclonal anti-CEA-antibodies.
    Kairemo KJ; Aronen HJ; Liewendahl K; Paavonen T; Heikkonen JJ; Virkkunen P; Mäki-Hokkonen H; Karonen SL; Brownell AL; Mäntylä MJ
    Acta Oncol; 1993; 32(7-8):771-8. PubMed ID: 8305225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations.
    Macmillan CH; Perkins AC; Wastie ML; Leach IH; Morgan DA
    Br J Cancer; 1993 Jun; 67(6):1391-4. PubMed ID: 8390288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoscintigraphy of colorectal carcinomas with radiolabeled monoclonal antibody fragments.
    Obradovic V; Artiko V; Petrovic M; Stefanovic B; Krivokapic Z; Zuvela M; Stojkovic M; Stefanovic B; Milovanovic A; Vlajkovic M
    Hepatogastroenterology; 2006; 53(70):526-30. PubMed ID: 16995454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.
    Vuillez JP; Peltier P; Caravel JP; Chetanneau A; Saccavini JC; Chatal JF
    J Clin Endocrinol Metab; 1992 Jan; 74(1):157-63. PubMed ID: 1727816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoscintigraphy of gastric or colon carcinoma with F(ab')2 fragments of anti-CEA monoclonal antibody.
    Amendolagine F; Allegra V; Tenti M; Lobrano V; Pannozzo G
    Rays; 1987; 12(1):67-71. PubMed ID: 3628863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.